CCND1 and cancer: The binding of AZIN1 inhibits antizyme-1-mediated binding and degradation of the ornithine decarboxylase (ODC) and cyclin D1 (CCND1) oncoproteins, contributing to cancer initiation and progression, and controlling the proliferative and invasive abilities of cells.